title: A review on thromboprophylaxis in pregnancy.
abstract: Thromboembolic disease remains an important cause of maternal mortality worldwide. The risk assessments for prevention of thromboembolism in pregnancy are controversial due to lack of large-scale randomised controlled trials. Unfractionated heparin is at present, the anticoagulant of choice during pregnancy. However, it may be superseded by low-molecular-weight heparin in the near future because of its safety and efficacy.
authors.affiliation: Department of Obstetrics and Gynaecology, University Malaya Medical Centre, Kuala Lumpur.
authors.forename: T W
authors.initials: TW
authors.lastname: Chow
authors.forename: Y M
authors.initials: YM
authors.lastname: Wong
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D005260:Female; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications / Q000517:prevention & control*; D013923:Thromboembolism / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D006493:Heparin